Select Page

H.R.4396

Heroin and Prescription Drug Abuse Prevention
and Reduction Act

Introduced on 01/28/2016 by Frank Pallone [D-NJ-6]. Referred to the Energy & Commerce, Judiciary, Ways & Means, and Education and the Workforce Committees. Then referred to the Subcommittee on Health, Employment, Labor, and Pensions. Cosponsors of the Bill are David Loebsack [D-IA-2], Paul Tonko [D-NY-20], Yvette Clarke [D-NY-9], Ben Ray Lujan [D-NM-3], Brad Ashford [D-NE-2], Doris Matsui [D-CA-6], Joseph Kennedy [D-MA-4], John Yarmuth [D-KY-3], Alan Grayson [D-FL-9] , Eddie Bernice Johnson [D-TX-30], Donald Payne [D-NJ-10], Theodore Deutch [D-FL-21], Chris Van Hollen [D-MD-8], Eliot Engel [D-NY-16], Mark Takano [D-CA-41], Janice Schakowsky [D-IL-9], Eleanor Norton [D-DC-At Large], Tony Cardenas [D-CA-29], Tammy Duckworth [D-IL-8], Mark DeSaulnier, Diana DeGette [D-CO-1], Earl Blumenauer [D-OR-3], Peter Welch {D=VT-At Large], Derek Kilmer [D-WA-6], Chellie Pingree [D-ME-1], Gwen Moore [D-WI-4], Lois Capps [D-CA-24], Charles Rangel [D-NY-13], Eric Swalwell [D-CA-15], Sander Levin [D-MI-9] Alcee Hastings [D-FL-20], and Marcy Kaptur [D-OH-9]. Related Bills are H.R 2536, H.R.3680, H.R.3691, H.R.4276, H.R.4435, H.R.4982, S.1455, S.2226, and S.2462.

This Bill is identical to S.2562, introduced on 2-22-16 and referred to the Committee on Health, Education, Labor and Pensions.

Purpose: A comprehensive public health response to the heroin and prescription drug abuse crisis.

TITLE I—PREVENTION

SEC. 101. Practitioner education.

(a) Education requirements.—

(1) REGISTRATION CONSIDERATION.—amends Section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f))—the section listing reasons to deny registration based on being “inconsistent with public interest” by adding:

“(6) The applicant’s compliance with the training requirements described in subsection (g)(3) during any previous period in which the applicant has been subject to such training requirements.”.

(2) TRAINING REQUIREMENTS.—Amends section 303(g) with:

“(3) (A) To be registered to prescribe or otherwise dispense opioids for the treatment of pain, or pain management, a practitioner described in paragraph (1) shall comply with the 12-hour training requirement of subparagraph (B) at least once during each 3-year period or the requirements of a State training program approved by the Secretary of Health and Human Services under subparagraph (C).

“(B) 12 hours of training is with respect to treatment and management of opioid-dependent patients, pain management treatment guidelines; and early detection of opioid addiction. State training programs may comply.

Funding of enforcement of the requirements is through The Drug Enforcement Administration using a portion of the licensing fees paid by controlled substance prescribers. Also $1,000,000 is appropriated for each of fiscal years 2017 through 2021.

SEC. 102. Co-prescribing opioid overdose reversal drugs grant program.

Allows for a four-year co-prescribing opioid overdose reversal drugs grant program for not more than a total of 12 grants. Co-prescribing is the practice of prescribing an opioid overdose reversal drug in conjunction with an opioid prescription for patients at an elevated risk of overdose and for the treatment of opioid abuse disorders.

SEC. 103. Opioid overdose reversal co-prescribing guidelines.

Allows for grants to eligible State entities to develop opioid overdose reversal co-prescribing guidelines at not than $200,000 per grant.

SEC. 104. Surveillance capacity building—Allows for grants for improving the ID of deaths due to overdose, involving training and improved data collection.
TITLE II—CRISIS

SEC. 201. Grants to support syringe exchange programs providing outreach, counseling, health education, case management, syringe disposal, and other services as appropriate; and technical assistance, including $15,000,000 for each of fiscal years 2017 through 2021.

SEC. 202. Grant program to reduce drug overdose deaths by distributing the drug naloxone, educating prescribers and pharmacists about overdose prevention and naloxone prescription, training first responders, educating the public and providing outreach to the public about overdose prevention and naloxone prescriptions. Establish a coordinating center for the collecting, compiling, and disseminating data on the programs and activities under this section, developing best practices for preventing deaths occurring from drug overdoses; $20,000,000 authorized for each of the fiscal years 2017 through 2021.

TITLE III-TREATMENT

SEC. 301. Expansion of patient limits under waiver. Raises the maximum number of patients a doctor can treat with opioid management drugs from 100 to 250 over 3 years with certain requirements. Evaluation of the effects of this expansion to be carried out 2 years later.

SEC. 304. Reauthorizes residential treatment programs for pregnant and postpartum women, allowing $40,000,000 for each of fiscal years 2017 through 2021.

SEC. 305. Grants for State substance abuse agencies designed to support family-based services for pregnant and postpartum women with a primary diagnosis of a substance use disorder, including opioid use disorders;

(3) NATURE OF ACTIVITIES.—The grant funds awarded under paragraph (1) shall be used for activities that are based on reliable scientific evidence of efficacy in the treatment of problems related to heroin or other opioids.

SEC. 307. Grants to improve access to treatment and recovery for adolescents. $25,000,000 is authorized for each of fiscal years 2017 through 2021.

SEC. 308. Strengthening parity in mental health and substance use disorder benefits.

This section pertains to getting these services covered by insurance.

SEC. 309. Study on treatment infrastructure.

Not later than 24 months after the date of enactment of this Act, the Comptroller General of the United States shall initiate an evaluation, and submit to Congress a report, of the inpatient and outpatient treatment capacity, availability, and needs of the United States.

SEC. 310. Substance use disorder professional loan repayment program.

“(a) Establishment.—The Secretary shall establish and carry out a substance use disorder health professional loan repayment program under which qualified health professionals agree to be employed full-time for a specified period (which shall be not less than 2 years) in providing substance use disorder prevention and treatment services in underserved areas.

 TITLE IV—Recovery

SEC. 401. National youth recovery initiative.

a program to help individuals who are recovering from substance use disorders to initiate, stabilize, and maintain healthy and productive lives in the community; and includes peer-to-peer support and communal activities to build recovery skills and supportive social networks.

(4) The Secretary of HHS may award grants to provide substance use recovery support services to young people in high school and enrolled in institutions of higher education; authorized $30,000,000 for each of fiscal years 2017 through 2021.
SEC. 402. Grants to enhance and expand recovery support services.

The Secretary of HHS shall award grants to State substance abuse agencies and nonprofit organizations to develop, expand, and enhance recovery support services for individuals with substance use disorders involving education, mentoring, peer recovery support services, recovery-focused community education and outreach programs, programs aimed at identifying and reducing stigma and discriminatory practices that serve as barriers to substance use disorder recovery and treatment of these disorders, partnerships between public and private substance use disorder treatment programs and systems, health care providers, recovery-focused addiction and recovery professionals, faith-based organizations, organizations focused on criminal justice reform, schools and social service agencies$100,000,000 authorized for each of fiscal years 2017 through 2021.

 

Facebooktwitterlinkedinrssyoutube

Submit a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: